HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - dawn+cochrane
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Anti-androgen therapy in triple-negative breast cancer
Methods of treating breast cancer with anti-androgen compounds. Reference patent 9,517,229 and application 15/373,914.
Published: 12/1/2023
|
Inventor(s):
Jennifer Richer Mouchantat
,
Dawn Cochrane
,
Andy Protter
Disease Areas
Oncology
Category(s):
Therapeutics
Micro RNAs that target metabolic enzymes and nutrient transporters in breast cancer
Patients with triple-negative breast cancer often have increased risk for recurrence and metastasis as well as decreased 5-year survival. Since triple-negative breast cancers don’t depend on hormone receptors or HER for growth, triple-negative cancers do not respond to hormone or HER dependent therapies. Jennifer Richer and her research team have...
Published: 11/30/2023
|
Inventor(s):
Jennifer Richer Mouchantat
,
Dawn Cochrane
,
Steven Anderson
Disease Areas
Endocrine/Metabolism
,
Oncology
Category(s):
Diagnostics
Home
|
Search
|
RSS
|
Subscribe
For inquiries, email: cuinnovations@cuanschutz.edu. © 2024. All Rights Reserved. Powered by
Inteum